発症11年経過後に実施したステロイドパルス療法が有効であった,成人発症型Rasmussen脳炎の1例

症例は48歳男性.37歳,全身けいれん,失語で発症し,左側大脳半球のT2高信号域を認め,carbamazepine, sodium valproateを開始した.42歳,右半身不全麻痺が出現し,48歳,二次性全般化発作が頻回となり,失語,歩行障害が進行した.頭部MRI上,左側大脳半球が高度に萎縮し,脳波で左側前頭極に焦点のある鋭波を認めた.血清,髄液で抗GluN2B抗体が陽性であった.一側性大脳半球萎縮,焦点性てんかん発作があり,知的退行,運動障害が進行性であるため,Rasmussen脳炎と診断し,ステロイドパルス療法を施行した.治療後,二次性全般化発作の頻度が減り,自立歩行も可能となった.R...

Full description

Saved in:
Bibliographic Details
Published in神経治療学 Vol. 34; no. 5; pp. 543 - 546
Main Authors 長谷川, 直哉, 高橋, 哲哉, 小池, 亮子, 松原, 奈絵, 高橋, 幸利, 黒羽, 泰子, 谷, 卓, 長谷川, 有香
Format Journal Article
LanguageJapanese
Published 日本神経治療学会 2018
Japanese Society of Neurological Therapeutics
Subjects
Online AccessGet full text
ISSN0916-8443
2189-7824
DOI10.15082/jsnt.34.5_543

Cover

Abstract 症例は48歳男性.37歳,全身けいれん,失語で発症し,左側大脳半球のT2高信号域を認め,carbamazepine, sodium valproateを開始した.42歳,右半身不全麻痺が出現し,48歳,二次性全般化発作が頻回となり,失語,歩行障害が進行した.頭部MRI上,左側大脳半球が高度に萎縮し,脳波で左側前頭極に焦点のある鋭波を認めた.血清,髄液で抗GluN2B抗体が陽性であった.一側性大脳半球萎縮,焦点性てんかん発作があり,知的退行,運動障害が進行性であるため,Rasmussen脳炎と診断し,ステロイドパルス療法を施行した.治療後,二次性全般化発作の頻度が減り,自立歩行も可能となった.Rasmussen脳炎は,主に小児期に発症する自己免疫性てんかんで,早期治療介入が予後を改善する.本症例は,長期経過後の導入にもかかわらずステロイドパルス療法が有効であった.成人発症の緩徐進行性難治性てんかんでは,同疾患の可能性も疑い,長期経過例でも免疫療法を検討する必要があると思われる.
AbstractList Refractory epilepsy, right hemiplegia, and impaired fluency of expression had progressed over a period of 10 years in a 48–year–old male who had initially been diagnosed with secondary generalized seizures and aphasia. He was also unable to walk without support and levels of anti–N–methyl–D–aspartate type glutamate receptor subunit antibody were elevated in serum and cerebrospinal fluid. T2–weighted and fluid attenuated inversion recovery brain imaging showed hyperintensity on paraventricular white matter and EEG revealed a sharp wave with a front pole focus in the left cerebral cortex, where atrophy was more prominent. The brain MRI findings were worse at ten years than at two years after onset. He was diagnosed with Rasmussen's encephalitis based on the Bien diagnostic criteria and underwent high–dose intravenous methylprednisolone pulse (IVMP) therapy. Thereafter, he was able to walk without support for over 100 meters and the secondary generalized seizures and aphasia were improved. Rasmussen's encephalitis tends to progress more slowly in cases of adult onset than in childhood onset. The frequency of epilepsy increases and motor and cognitive decline progresses within months without immediate immunomodulation therapy. However, the frequency of epilepsy, gait disturbance, and aphasia was improved in our patient despite IVMP therapy being implemented eleven years after onset. Slowly progressive, refractory epilepsy of adult onset should be carefully assessed because immunomodulation therapy could be effective even if Rasmussen's encephalitis is diagnosed late. 症例は48歳男性.37歳,全身けいれん,失語で発症し,左側大脳半球のT2高信号域を認め,carbamazepine, sodium valproateを開始した.42歳,右半身不全麻痺が出現し,48歳,二次性全般化発作が頻回となり,失語,歩行障害が進行した.頭部MRI上,左側大脳半球が高度に萎縮し,脳波で左側前頭極に焦点のある鋭波を認めた.血清,髄液で抗GluN2B抗体が陽性であった.一側性大脳半球萎縮,焦点性てんかん発作があり,知的退行,運動障害が進行性であるため,Rasmussen脳炎と診断し,ステロイドパルス療法を施行した.治療後,二次性全般化発作の頻度が減り,自立歩行も可能となった.Rasmussen脳炎は,主に小児期に発症する自己免疫性てんかんで,早期治療介入が予後を改善する.本症例は,長期経過後の導入にもかかわらずステロイドパルス療法が有効であった.成人発症の緩徐進行性難治性てんかんでは,同疾患の可能性も疑い,長期経過例でも免疫療法を検討する必要があると思われる.
症例は48歳男性.37歳,全身けいれん,失語で発症し,左側大脳半球のT2高信号域を認め,carbamazepine, sodium valproateを開始した.42歳,右半身不全麻痺が出現し,48歳,二次性全般化発作が頻回となり,失語,歩行障害が進行した.頭部MRI上,左側大脳半球が高度に萎縮し,脳波で左側前頭極に焦点のある鋭波を認めた.血清,髄液で抗GluN2B抗体が陽性であった.一側性大脳半球萎縮,焦点性てんかん発作があり,知的退行,運動障害が進行性であるため,Rasmussen脳炎と診断し,ステロイドパルス療法を施行した.治療後,二次性全般化発作の頻度が減り,自立歩行も可能となった.Rasmussen脳炎は,主に小児期に発症する自己免疫性てんかんで,早期治療介入が予後を改善する.本症例は,長期経過後の導入にもかかわらずステロイドパルス療法が有効であった.成人発症の緩徐進行性難治性てんかんでは,同疾患の可能性も疑い,長期経過例でも免疫療法を検討する必要があると思われる.
Author 黒羽, 泰子
小池, 亮子
谷, 卓
長谷川, 有香
高橋, 幸利
松原, 奈絵
長谷川, 直哉
高橋, 哲哉
Author_FL Takahashi Yukitoshi
Tani Takashi
Hasegawa Naoya
Takahashi Tetsuya
Hasegawa Arika
Kuroha Yasuko
Matsubara Nae
Koike Ryoko
Author_FL_xml – sequence: 1
  fullname: Kuroha Yasuko
– sequence: 2
  fullname: Hasegawa Naoya
– sequence: 3
  fullname: Hasegawa Arika
– sequence: 4
  fullname: Tani Takashi
– sequence: 5
  fullname: Takahashi Tetsuya
– sequence: 6
  fullname: Matsubara Nae
– sequence: 7
  fullname: Takahashi Yukitoshi
– sequence: 8
  fullname: Koike Ryoko
Author_xml – sequence: 1
  fullname: 長谷川, 直哉
  organization: 国立病院機構西新潟中央病院てんかんセンター
– sequence: 1
  fullname: 高橋, 哲哉
  organization: 国立病院機構西新潟中央病院神経内科
– sequence: 1
  fullname: 小池, 亮子
  organization: 国立病院機構西新潟中央病院神経内科
– sequence: 1
  fullname: 松原, 奈絵
  organization: 国立病院機構西新潟中央病院神経内科
– sequence: 1
  fullname: 高橋, 幸利
  organization: 国立病院機構静岡てんかん・神経医療センター
– sequence: 1
  fullname: 黒羽, 泰子
  organization: 国立病院機構西新潟中央病院神経内科
– sequence: 1
  fullname: 谷, 卓
  organization: 国立病院機構西新潟中央病院神経内科
– sequence: 1
  fullname: 長谷川, 有香
  organization: 国立病院機構西新潟中央病院神経内科
BackLink https://cir.nii.ac.jp/crid/1390282679613487744$$DView record in CiNii
BookMark eNo9kL1KA0EUhQdRMEZbn8B248zO7MxsI4j4B4IgWi-TyUQ3xFWysbARZlf8DaKFiiBaKFiINtEiQfMyk81q5SsYjdicC_ec-8E9Q6A_2AgUAKMI5pADuT1eCoNqDpOc4zkE94GMjbhrMW6TfpCBLqIWJwQPgpEw9PMQEggR4ywDdtKrZnq5j1DSeElfa5_6JGnVjH5Mnm87F-9GXxp9a6KGifdM_GSiexMfmvjMxI_dZXoVdernRtc614fJUcPoB6Mjo--6J19vtc7BabvZ7OGTm-MlEa5vhaEKPnbraXRi9DNqt46HwUBRlEM18jezYGVmenlqzlpYnJ2fmlywSjZkxHKolJS6Sri2YgUhEHGILDKOul8wrCjH0laCugRTyLibR1IVCS3gfAGKAkUSZ8FYjxv4vif9H0XYhTa3KXMpwoQz1u0nCyZ6sVJYFavK26z466Ky7YlK1Zdl5f2U7GHiOb9C8L8h10TFKwn8DbUAnsQ
ContentType Journal Article
Copyright 2018 日本神経治療学会
Copyright_xml – notice: 2018 日本神経治療学会
DBID RYH
DOI 10.15082/jsnt.34.5_543
DatabaseName CiNii Complete
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Adult–onset Rasmussen encephalitis with high anti N–methyl–D aspartate type glutamate receptor subunit antibody titer in serum and cerebrospinal fluid : Effects of high–dose intravenous methylprednisolone pulse therapy implemented eleven years after onset
DocumentTitle_FL Adult–onset Rasmussen encephalitis with high anti N–methyl–D aspartate type glutamate receptor subunit antibody titer in serum and cerebrospinal fluid : Effects of high–dose intravenous methylprednisolone pulse therapy implemented eleven years after onset
EISSN 2189-7824
EndPage 546
ExternalDocumentID 130006638848
article_jsnt_34_5_34_543_article_char_ja
GroupedDBID ABJNI
ALMA_UNASSIGNED_HOLDINGS
JSF
KQ8
MOJWN
RJT
RYH
ID FETCH-LOGICAL-j2074-56cc669ea92e7daa1454cf78101773e683c2ea694360789b1cef46d3bd0ad61c3
ISSN 0916-8443
IngestDate Fri Jun 27 00:10:51 EDT 2025
Wed Sep 03 06:14:26 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue 5
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j2074-56cc669ea92e7daa1454cf78101773e683c2ea694360789b1cef46d3bd0ad61c3
OpenAccessLink https://www.jstage.jst.go.jp/article/jsnt/34/5/34_543/_article/-char/ja
PageCount 4
ParticipantIDs nii_cinii_1390282679613487744
jstage_primary_article_jsnt_34_5_34_543_article_char_ja
PublicationCentury 2000
PublicationDate 2018
PublicationDateYYYYMMDD 2018-01-01
PublicationDate_xml – year: 2018
  text: 2018
PublicationDecade 2010
PublicationTitle 神経治療学
PublicationTitleAlternate 神経治療
PublicationTitle_FL Neurol Therap
神経治療
Neurological Therapeutics
PublicationYear 2018
Publisher 日本神経治療学会
Japanese Society of Neurological Therapeutics
Publisher_xml – name: 日本神経治療学会
– name: Japanese Society of Neurological Therapeutics
References 3) Bien CG, Granata T, Antozzi C : Pathogenesis, diagnosis and treatment of Rasmussen encephalitis : a European consensus statement. Brain 128 : 454–471, 2005
6) McLachlan RS, Girvin JP, Blume WT : Rasmussen's chronic encephalitis in adults. Arch Neurol 50 : 269–274, 1993
4) Bien CG, Widman G, Urbach H : The natural history of Rasmussen's encephalitis. Brain 125 : 1751–1759, 2002
2) Fukuyama T, Takahashi Y, Kubota Y et al : Semi–quantitative analyses of antibodies to N–methyl–d–aspartate type glutamate receptor subunits (GluN2B & GluN1) in the clinical course of Rasmussen syndrome. Epilepsy Res 113 : 34–43, 2015
8) Villani F, Spreafico R, Farina L : Positive response to immunomodulatory therapy in an adult patient with Rasmussen's encephalitis. Neurology 56 : 248–250, 2001
10) Villani F, Pincherle A, Antozzi C et al : Adult–onset Rasmussen's encephalitis : anatomical–electrographic–clinical features of 7 Italian cases. Epilepsia 47(Suppl 5) : 41–46, 2006
7) Vadlamudi L, Galton CJ, Jeavons SJ : Rasmussen's syndrome in a 54 year old female : more support for an adult variant. J Clin Neurosci 7 : 154–156, 2000
9) Frucht S : Dystonia, athetosis, and epilepsia partialis continua in a patient with late–onset Rasmussen's encephalitis. Mov Disord 17 : 609–612, 2002
5) Gray F, Serdaru M, Baron H : Chronic localised encephalitis (Rasmussen's) in an adult with epilepsia partialis continua. J Neurol Neurosurg Psychiatry 50 : 747–751, 1987
1) Rasmussen T, Olszewski J, Lloydsmith D : Focal seizures due to chronic localized encephalitis. Neurology 8 : 435–445, 1958
11) Deleo F, Matricardi S, Didato G et al : The dilemma of adult–onset Rasmussen encephalitis clinical assessment : Proposal for a new bedside tool to evaluate disease progression. Epilepsy Behav 46 : 249–251, 2015
References_xml – reference: 4) Bien CG, Widman G, Urbach H : The natural history of Rasmussen's encephalitis. Brain 125 : 1751–1759, 2002
– reference: 3) Bien CG, Granata T, Antozzi C : Pathogenesis, diagnosis and treatment of Rasmussen encephalitis : a European consensus statement. Brain 128 : 454–471, 2005
– reference: 6) McLachlan RS, Girvin JP, Blume WT : Rasmussen's chronic encephalitis in adults. Arch Neurol 50 : 269–274, 1993
– reference: 10) Villani F, Pincherle A, Antozzi C et al : Adult–onset Rasmussen's encephalitis : anatomical–electrographic–clinical features of 7 Italian cases. Epilepsia 47(Suppl 5) : 41–46, 2006
– reference: 5) Gray F, Serdaru M, Baron H : Chronic localised encephalitis (Rasmussen's) in an adult with epilepsia partialis continua. J Neurol Neurosurg Psychiatry 50 : 747–751, 1987
– reference: 7) Vadlamudi L, Galton CJ, Jeavons SJ : Rasmussen's syndrome in a 54 year old female : more support for an adult variant. J Clin Neurosci 7 : 154–156, 2000
– reference: 9) Frucht S : Dystonia, athetosis, and epilepsia partialis continua in a patient with late–onset Rasmussen's encephalitis. Mov Disord 17 : 609–612, 2002
– reference: 2) Fukuyama T, Takahashi Y, Kubota Y et al : Semi–quantitative analyses of antibodies to N–methyl–d–aspartate type glutamate receptor subunits (GluN2B & GluN1) in the clinical course of Rasmussen syndrome. Epilepsy Res 113 : 34–43, 2015
– reference: 8) Villani F, Spreafico R, Farina L : Positive response to immunomodulatory therapy in an adult patient with Rasmussen's encephalitis. Neurology 56 : 248–250, 2001
– reference: 1) Rasmussen T, Olszewski J, Lloydsmith D : Focal seizures due to chronic localized encephalitis. Neurology 8 : 435–445, 1958
– reference: 11) Deleo F, Matricardi S, Didato G et al : The dilemma of adult–onset Rasmussen encephalitis clinical assessment : Proposal for a new bedside tool to evaluate disease progression. Epilepsy Behav 46 : 249–251, 2015
SSID ssib004001787
ssib005902298
ssib000872158
ssj0003304805
ssib058494376
Score 1.7369283
Snippet 症例は48歳男性.37歳,全身けいれん,失語で発症し,左側大脳半球のT2高信号域を認め,carbamazepine, sodium valproateを開始した.42歳,右半身不全麻痺が出現し,48...
Refractory epilepsy, right hemiplegia, and impaired fluency of expression had progressed over a period of 10 years in a 48–year–old male who had initially been...
SourceID nii
jstage
SourceType Publisher
StartPage 543
SubjectTerms adult–onset Rasmussen's encephalitis
anti N–methyl–D–aspartate type glutamate receptor subunits antibody
focal progressive cerebral atrophy
slowly progressive refractory epilepsy
steroid pulse therapy
Title 発症11年経過後に実施したステロイドパルス療法が有効であった,成人発症型Rasmussen脳炎の1例
URI https://www.jstage.jst.go.jp/article/jsnt/34/5/34_543/_article/-char/ja
https://cir.nii.ac.jp/crid/1390282679613487744
Volume 34
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 神経治療学, 2018, Vol.34(5), pp.543-546
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2189-7824
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0003304805
  issn: 0916-8443
  databaseCode: KQ8
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Pa9RAFA9tRfAiior_Kj04p5J1k0wmmWOyzVIEBaWF3kKSzcIuuIrdXjwI2RW1dil60FIQe1DwUOylemjRfpl0d_XkV_C9yWSbhYJVKNPpm_fevPnNZufN68yLotw0dVqLA5ursVmnKjXKocp53VDrESsH1AhqvI4Xhe_cZfOL9PaSuTQxdbpwammlHZaiJ8feK_mfWQUazCvekv2HmR0pBQLUYX6hhBmG8kRzTDyLcE5cR1QsAtsSjXgmcYFGkeaaxK4Qj4O_SGxPNHmCYiDFcZHieIRXiccIZ8Sdk02gTFaqoqKjTqzAD5MVZ042OTRvynm4lvO4BXFhLNShLxd4TNkF2gO9V4Q4GOzkfYGFuRkolVGMgmFV4lakuG0TXiYeRTAkHmPAoGYOY3fvB8sPVpYx7uTZxKZoCfCAfsQn68LThCLkLvruyOcILUfIwkhgbG5hbCbi4ozinQg-tHNdCHmA8Kwcv1uWzLxcZAZYXAttg3ZXmA0lRyn45Yp5BRsQ65NJjZDlYBXhBSnJPCtABzOMYgRILldiXQZ_Ct9TOjrhi0EmzOmSL5sLR3f4xkK_GlNtmqXHKsWCBp4eV8FbpMWVUYaZG8WzB2KZM3NZ-Rc7djEG3x-z-zaXW-2SQUumPxIbS3CO_1BFx9e2qT2pnNIxsIanK-4V9wkWuKZ2ceHRikmlMAeRfhQ3AKeaU0P62eiSYdDOzo4z52OXCVzRxltjFoIr2oSNGWbcmGw1GgVvc-GcclZuE2ec7Jk_r0w0gwvK0-Hm_nDjhab1974Ov_V-Jev9g16abPd3tgbvfqTJRppspZ29tPs87X5JO5_S7mrafZN2t4E43OwMdt-mSW_wfrX_ai9NPqdJJ00-gsjv773By9eH-_uZ-v6HtdEz8vPZ7rCzniY72uHB2kVlseotVOZV-f4UtanjMWuTRRFjPA64Hlu1INCoSaO6hSn9LMuImW1EehwwgIrhSydCLYrrlNWMsFYOakyLjEvKVOthK76szIQhD7S4zKIAFJtU44GlWZjVOqIRfqVfUawMNP9RliTHl1-KPmLrG9Q3RUGNUQPeKvWbIDkNKPtRA0vYjmIMCGPbmkFt2JrSq39pv6acwWcii4peV6baj1fiadgntMMb4jP0B-3M6WM
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E7%99%BA%E7%97%8711%E5%B9%B4%E7%B5%8C%E9%81%8E%E5%BE%8C%E3%81%AB%E5%AE%9F%E6%96%BD%E3%81%97%E3%81%9F%E3%82%B9%E3%83%86%E3%83%AD%E3%82%A4%E3%83%89%E3%83%91%E3%83%AB%E3%82%B9%E7%99%82%E6%B3%95%E3%81%8C%E6%9C%89%E5%8A%B9%E3%81%A7%E3%81%82%E3%81%A3%E3%81%9F%EF%BC%8C%E6%88%90%E4%BA%BA%E7%99%BA%E7%97%87%E5%9E%8BRasmussen%E8%84%B3%E7%82%8E%E3%81%AE1%E4%BE%8B&rft.jtitle=%E7%A5%9E%E7%B5%8C%E6%B2%BB%E7%99%82%E5%AD%A6&rft.au=%E9%BB%92%E7%BE%BD+%E6%B3%B0%E5%AD%90&rft.au=%E9%95%B7%E8%B0%B7%E5%B7%9D+%E7%9B%B4%E5%93%89&rft.au=%E9%95%B7%E8%B0%B7%E5%B7%9D+%E6%9C%89%E9%A6%99&rft.au=%E8%B0%B7+%E5%8D%93&rft.date=2018&rft.pub=Japanese+Society+of+Neurological+Therapeutics&rft.issn=0916-8443&rft.eissn=2189-7824&rft.volume=34&rft.issue=5&rft.spage=543&rft.epage=546&rft_id=info:doi/10.15082%2Fjsnt.34.5_543&rft.externalDocID=130006638848
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0916-8443&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0916-8443&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0916-8443&client=summon